Vimarsana
Biggest News Aggregation in the World

Page 36 - Xpected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xpected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xpected Today - Breaking & Trending Today

New Factory Branches In Ajloun, Mafraq, Maan, Karak Expected To Create 670 New Jobs - Vimarsana News

New Factory Branches In Ajloun, Mafraq, Maan, Karak Expected To Create 670 New Jobs

AMMAN - Royal Court Chief Yousef Issawi on Monday attended the signing of four agreements meant to establish new branches of factories and companies

Source: menafn.com
Abrdn sells HDFC stake; Lookers agrees to buyout - Vimarsana News

Abrdn sells HDFC stake; Lookers agrees to buyout

Stocks in London were expected to fall further on Tuesday's open, with investors awaiting UK inflation data and a Bank of England rate announcement later this week. The lack of any further details... | June 20, 2023

Land Survey Equipment Market Expected To Reach USD 13.4 Billion Forecast By 2030 - Vimarsana News

Land Survey Equipment Market Expected To Reach USD 13.4 Billion Forecast By 2030

The land survey equipment market is projected to reach $13.4 billion by 2030, At a CAGR of 6.1% from 2021 to 2030 PORTLAND, OR, U

Source: menafn.com
Olin Updates Second Quarter 2023 Outlook and Announces Additional Epoxy Restructuring Actions - Vimarsana News

Olin Updates Second Quarter 2023 Outlook and Announces Additional Epoxy Restructuring Actions

CLAYTON, Mo., June 20, 2023 /PRNewswire/ -- Olin Corporation announced today an updated outlook for the second quarter 2023. Olin's second quarter 2023 adjusted EBITDA is expected to be in the... | June 20, 2023

Regulus Therapeutics Announces Update on Preclinical Studies in Amyotrophic Lateral Sclerosis in Collaboration with Researchers from Harvard's Brigham and Women's Hospital - Vimarsana News

Regulus Therapeutics Announces Update on Preclinical Studies in Amyotrophic Lateral Sclerosis in Collaboration with Researchers from Harvard's Brigham and Women's Hospital

Program advances to lead compound evaluation in preclinical in vivo models Preliminary data for in vivo studies are expected in second half of 2023 SAN DIEGO, June 20, 2023 /PRNewswire/ -- Regulus... | June 20, 2023